Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Joly

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
AIDS Reviews|November 6, 2002
NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimensVéronique Joly, Diane Descamps, Patrick Yeni
Expert Opinion on Emerging Drugs|April 26, 2006
Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adultsClaude Fortin, Véronique Joly, Patrick Yeni
Expert Opinion on Pharmacotherapy|October 28, 2010
Enfuvirtide: from basic investigations to current clinical useVéronique Joly, Kaoutar Jidar, Mercedes Tatay, et al.
Virologie (Montrouge, France)|January 9, 2020
Antiretroviral treatments in 2012: improvements and future prospectsCharlotte Charpentier, Véronique Joly, Patrick Yeni, et al.
Acta Neurologica Belgica|April 2, 2015
Isolated blepharoptosis may point to HIV-associated Burkitt's lymphomaMaud Pichon, Julien Savatovsky, Cédric Lamirel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 29, 2008
Active tuberculosis does not always imply the initiation of highly active antiretroviral therapy in HIV-infected patientsAgnès Meybeck, Claude Fortin, Raymond Ruimy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2002
On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biasesPhilippe Flandre, Christine Durier, Diane Descamps, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Estimating and comparing reduction in HIV-1 RNA in clinical trials using methods for interval censored dataPhilippe Flandre, Alexandre Alcais, Diane Descamps, et al.
AIDS (London, England)|December 4, 2002
Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trialVéronique Joly, Philippe Flandre, Vincent Meiffredy, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2014
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimenCharlotte Charpentier, Véronique Joly, Jade Ghosn, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
AIDS Reviews|November 6, 2002
NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimensVéronique Joly, Diane Descamps, Patrick Yeni
Expert Opinion on Emerging Drugs|April 26, 2006
Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adultsClaude Fortin, Véronique Joly, Patrick Yeni
Expert Opinion on Pharmacotherapy|October 28, 2010
Enfuvirtide: from basic investigations to current clinical useVéronique Joly, Kaoutar Jidar, Mercedes Tatay, et al.
Virologie (Montrouge, France)|January 9, 2020
Antiretroviral treatments in 2012: improvements and future prospectsCharlotte Charpentier, Véronique Joly, Patrick Yeni, et al.
Acta Neurologica Belgica|April 2, 2015
Isolated blepharoptosis may point to HIV-associated Burkitt's lymphomaMaud Pichon, Julien Savatovsky, Cédric Lamirel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 29, 2008
Active tuberculosis does not always imply the initiation of highly active antiretroviral therapy in HIV-infected patientsAgnès Meybeck, Claude Fortin, Raymond Ruimy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2002
On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biasesPhilippe Flandre, Christine Durier, Diane Descamps, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Estimating and comparing reduction in HIV-1 RNA in clinical trials using methods for interval censored dataPhilippe Flandre, Alexandre Alcais, Diane Descamps, et al.
AIDS (London, England)|December 4, 2002
Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trialVéronique Joly, Philippe Flandre, Vincent Meiffredy, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2014
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimenCharlotte Charpentier, Véronique Joly, Jade Ghosn, et al.
Pageof 8